Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts
MercadoLibre, Novo Nordisk, Tyler Technologies and Summit Therapeutics trade below recent highs, yet each has earnings or catalysts that could shift sentiment.
MarketBeat ·